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A rapid and cost effective method for the analysis of metronidazole in biological samples was 
developed. The extraction method is a simple single-step liquid-liquid process that has eliminated the 
need for costly extraction and evaporation equipment. The mobile phase consists largely of water, 
making the method cheap to run with less than 6 min total analytical time per sample. The calibration 
curve was linear from 0 to 2.00 µg/ml. The regression coefficient was 0.99. The method is highly 
sensitive, with limit of detection of 1 ng/ml. The coefficient of variation for within-day run was less than 
4% while that of day-to-day run was less than 6%. There were no interfering peaks from endogenous 
materials in the serum. The method was validated and used for pharmacokinetic studies. 
 
 





Metronidazole is a 5-nitronimidazole derivative with 
activity against anaerobic protozoa and anaerobic 
bacteria. The drug is readily absorbed following oral 
administration. Metronidazole is widely distributed; it 
appears in most body tissues and fluids including bile, 
bone, breast milk, cerebral abscesses, saliva, and 
generally achieves concentrations similar to those in 
plasma. 
The choice of an analytical method is usually governed 
by the intrinsic analytical properties of the drug molecule 
or its amenability to chemical derivatisation to render it 
compatible to quantitation. In addition, such factors as 
sample size, sample environment, detection method and 
even the method for quantitation must be taken into 
account, since these affect the reliability of the 
quantitation. Various chromatography methods have 
been reported for the analysis of metronidazole in 
pharmaceutical dosage form and biological fluids (Akay 
et al., 2002; Yeung et al., 1998). Currently, reversed 
phase      and      ion-pair       high–performance       liquid  
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chromatography with UV detection represent the 
analytical method of choice for the quantitative 
determination of metronidazole in human plasma, urine 
and/or saliva (Jessa et al., 1996; Yeung et al., 1998; 
Galmier et al., 1998). The older methods used for the 
analysis of metronidazole required expensive reagents 
and elaborate extraction procedure. The present study 
aims to provide simple, sensitive and rapid but cost-
effective HPLC method of assaying metronidazole both in 





Reagents and solutions  
 
All the reagents used are analytical grades. Stock solutions (1 
mg/ml) of metronidazole and sulphamethoxazole (Reference 
Standards) were prepared in 0.1 N HCl. Each stock solution was 
protected from light, stored at 4ºC in the refrigerator and freshly 
diluted for analysis when needed. Metronidazole USP reference 
standard was obtained from Rockville, USA, while 
sulphamethoxazole was  obtained  from  Sigma  Aldrich,  USA and 
Hydrochloric acid Analar from BDH Chemical Ltd., Poole England. 
The HPLC grade  methanol was obtained from Sigma Aldrich.




Table 1. Within day and day-to-day precision for serum metronidazole determination. 
 
Parameter Concentration (µg/ml) % Coefficient of variation N 
0.10 3.2 5 
1.00 1.6 5 
Within- day run 
2.00 1.2 5 
0.10 5.5 5 
1.00 1.7 5 
Day-to-day 




Table 2. Percentage recoveries of metronidazole from different 
concentrations of rat serum. 
 













The chromatograms were from an Agilent 1100 series quartenary 
LC pump system, equipped with ultraviolet detector. Wavelength for 
detection was 276 nm. The stationary phase was a silica–based 
ultrasphere C-18 column (5 mm, 2.0 mm x 25 cm). The mobile 
phase consisted of methanol: water in a ratio of 25:75. The mobile 
phase was pumped through the column at ambient temperature 





Blood samples were collected into clean sample bottles from adult 
Wister rats for the calibration curves. Samples were then collected 
at time 0, 0.5, 1, 2, 3, 6 and 8 h interval after oral administration of 
metronidazole 7.5 mg/kg for the measurement of serum 
concentrations. All samples were centrifuged at 2000 g for 10 min 





Into 10-ml extraction tubes were placed 0.2 ml of serum spiked with 
200 ng sulphamethoxazole (I.S.). The mixture was made alkaline 
with 0.5 ml of 2 M NaOH and 2 ml of dichloromethane was added. 
The resulting mixture was then vortex mixed for 1 min. The tubes 
were centrifuged at 3000 g for 10 min and the organic layer was 
then transferred to fresh tubes and evaporated to dryness on the 
water   bath   at   temperature   40ºC.   The    dried    residue    was  
reconstituted with 100 µl of 0.1 N HCl. 20 µl aliquot was injected 
onto the HPLC system.  
Percentage recovery 
 
0.2 ml of blank rat serum was spiked with metronidazole standard 
solution to give predetermined concentrations. To each sample was 
added 200 ng of sulphamethoxazole (I.S.) and the resulting solution 
was taken through the extraction procedure previously described 
under serum extraction. The absolute recovery was determined by 
comparing the peak area ratios of extracted metronidazole standard 
with those obtained by direct injections of the same concentrations 





Calibration curves, which were based on peak-area ratio to the 
concentration of the drug, were prepared by spiking drug-free 
serum with a standard metronidazole (1 mg/ml) to give a 
concentration range of 0-2.00 µg/ml and same quantity of 
sulphamethoxazole (200 ng) was added. The level of metronidazole 
in an unknown sample was derived from these values. 
 
 
Precision of the method  
 
0.2 ml of blank serum was spiked with metronidazole standard 
solution to give predetermined concentrations. To each sample was 
added 200 ng of internal standard and the resulting solution was 
taken through the extraction procedure previously described. The 
precision was estimated by computing the peak area ratio and the 
coefficient of variation (CV) of the three different concentrations for 




Lower limit of quantitation 
 
Limit of detection of the drug was checked from the direct injection 
of diluted samples from the stock solution. 
 
 
RESULT AND DISCUSSION 
 
The method is highly sensitive, with the lower limit of 
quantitation of metronidazole at 1 ng/ml. The coefficient 
of variation for within- day was less than 4% while that of 
day-to-day-run was less than 6% (Table 1) and the 
extraction efficiency was high with percentage recoveries 
>98% (Table 2). The calibration curve was linear in 
serum with a regression of r=0.9998 as shown in Figure 
1. 

























Figure 2. Chromatogram of blank rat serum spiked with 
metronidazole (2 g/ml) and sulphamethoxazole (200 ng) 



























Figure 4. Serum concentration-time curve of metronidazole 





The resultant chromatograms from the system HPLC 
with metronidazole and I.S showed that the HPLC 
method developed is selective as it provided a good 
resolution of metronidazole from the internal standard 
and there was no interference from endogenous 
materials. The retention times of metronidazole and 
sulphamethoxazole (I.S) were 4.5 and 3.2 min 
respectively (Figures 2 and 3). The single extraction step 
using a small volume of serum (0.2 ml) with less than 6 
min total analytical time per sample is appropriate for a 





about 12 samples per h. It is noteworthy that no 
metabolite was detected in this study, which is in 
agreement with other published studies (Menelaou et al., 
1999; Akay et al., 2002; Klimowicz et al., 2002).  
Despite the fact that many modern HPLC methods 
have been described for the assay of metronidazole 
(Klimowicz et al., 2002; Wibawa et al., 2001; Menelaou et 
al., 1999), there is justification for investigating newer 
methods, especially where they are more cost-effective 
and there is an appreciable reduction in the procedural 
time compared to older methods. The use of expensive 
evaporating equipment is circumvented since very small 
quantity of organic solvent was used. It may be applied to 
both research and therapeutic drug monitoring as 
demonstrated by the concentration time curves 
(pharmacokinetic curve in Figure 4).  
In conclusion, the HPLC assay method developed in 
this study using a reversed-phase system was found to 
be simple, cost-effective and sensitive for assaying 





We acknowledge the National Institute for 
Pharmaceutical Research and Development, Idu-Abuja, 





Akay C, Ozkan SA, Senturk Z, Cevheroglu S (2002). Simultaneous 
determination of metronidazole and miconazole in pharmaceutical 
dosage form by HPLC. Farmaco. Nov.57(11): 953-7. 
Galmier MJ, Frasey AM, Bastide M, Beyssac E, Petit J, Aiache JM, 
Lartigue-Mattei (1998). Simple and sensitive method for 
determination of metronidazole in human serum by high performance 
liquid chromatography. J. Biomed. Sci. Appl. 11: 720 (1-2): 239-43. 
Jessa MJ, Barrett DA, Shaw PN, Spiller RC (1996). Rapid and selected 
high-performance liquid- chromatographic method for determination 
of metronidazole and its active metabolite in human plasma, saliva 
and gastric juice. J. Chromatograp.  Biomed Appl. 3, 677(2): 374-9. 
 Klimowicz A, Bielecka-Grzela S, Tomaszewska U (2002). A simple and 
rapid Liquid chromatographic method for the determination of 
metronidazole and its metabolites in plasma and cutaneous 
microdialysates. Acta Pol Pharm. 59(5): 327-31. 
Menelaou A, Somogyi  AA, Barclay ML, Bochner F (1999). 
Simultaneous quantification of amoxycillin and metronidazole in 
plasma using high-performance liquid chromatography with diode 
array detection. J. Biomed. Sci. Appl. 20; 731 (2): 261-6. 
Nagaraja P,  Sunitha KR, Vasantha RA, Yathirajan HS (2002). 
Spectrophotometric determination of metronidazoleand tinidazole in 
pharmaceutical preparations. J Pharmaceut. Biomed. Anal.. 28: 527-
535. 
Wibawa JD, Shaw PN, Barrett DA (2001). Quantification of 
metronidazole in small volume biological samples using narrow bore 
high–performance liquid chromatography. J. Chromatograph. Biomed 
Sci Appl. 25:  761 (2): 213-9. 
Yeung PK, Little R, Jiang Y, Buckley SJ, Pollak PT,  Kapoor H,  Zanten 
SJ. (1998). A simple high performance liquid chromatography assay 
for simultaneous determination of omeprazole and metronidazole in 
human plasma and gastric fluid. J. Pharm. B. Biomed  Anal.  17(8):  
1393-8. 
